Sign in
4

Changes in Ownership

Bausch Health Companies Inc. Filed Acc 0001127602-22-012006

U.S. President-Pharma Business sold 1,595 shares at $22.19 ($35,393)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Spurr Robert U.S. President-Pharma Business 2022-04-14 Sale −1,595 $22.19 $35,393 90,506 D
Open-market sales · 1,595 sh · avg $22.19 · $35,393
Loading xslF345X03/form4.xml…